Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

CXCR2 in skin cells promotes tumor growth.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Tofacitinib might be used to treat hair loss.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Orlistat might block the body's ability to absorb thyroid medication.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.